115 related articles for article (PubMed ID: 23980054)
1. [Research progression in tumor-infiltration lymphocytic cells in colorectal cancer].
Zhai ZW; Wang ZJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Aug; 16(8):797-800. PubMed ID: 23980054
[TBL] [Abstract][Full Text] [Related]
2. Correlation between Density of CD8+ T-cell Infiltrate in Microsatellite Unstable Colorectal Cancers and Frameshift Mutations: A Rationale for Personalized Immunotherapy.
Maby P; Tougeron D; Hamieh M; Mlecnik B; Kora H; Bindea G; Angell HK; Fredriksen T; Elie N; Fauquembergue E; Drouet A; Leprince J; Benichou J; Mauillon J; Le Pessot F; Sesboüé R; Tuech JJ; Sabourin JC; Michel P; Frébourg T; Galon J; Latouche JB
Cancer Res; 2015 Sep; 75(17):3446-55. PubMed ID: 26060019
[TBL] [Abstract][Full Text] [Related]
3. Characterization of tumour-infiltrating lymphocytes and apoptosis in colitis-associated neoplasia: comparison with sporadic colorectal cancer.
Michael-Robinson JM; Pandeya N; Walsh MD; Biemer-Huttmann AE; Eri RD; Buttenshaw RL; Lincoln D; Clouston AD; Jass JR; Radford-Smith GL
J Pathol; 2006 Feb; 208(3):381-7. PubMed ID: 16315333
[TBL] [Abstract][Full Text] [Related]
4. The "Fas counterattack" is not an active mode of tumor immune evasion in colorectal cancer with high-level microsatellite instability.
Houston AM; Michael-Robinson JM; Walsh MD; Cummings MC; Ryan AE; Lincoln D; Pandeya N; Jass JR; Radford-Smith GL; O'Connell J
Hum Pathol; 2008 Feb; 39(2):243-50. PubMed ID: 17961631
[TBL] [Abstract][Full Text] [Related]
5. Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status.
Michael-Robinson JM; Pandeya N; Cummings MC; Walsh MD; Young JP; Leggett BA; Purdie DM; Jass JR; Radford-Smith GL
J Pathol; 2003 Sep; 201(1):46-54. PubMed ID: 12950016
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of combined tumour-infiltrating lymphocytes and microsatellite instability status in colorectal cancer: a systematic review and network meta-analysis.
Wankhede D; Yuan T; Kloor M; Halama N; Brenner H; Hoffmeister M
Lancet Gastroenterol Hepatol; 2024 Jul; 9(7):609-619. PubMed ID: 38734024
[TBL] [Abstract][Full Text] [Related]
7. Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases.
Buckowitz A; Knaebel HP; Benner A; Bläker H; Gebert J; Kienle P; von Knebel Doeberitz M; Kloor M
Br J Cancer; 2005 May; 92(9):1746-53. PubMed ID: 15856045
[TBL] [Abstract][Full Text] [Related]
8. Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma.
Smyrk TC; Watson P; Kaul K; Lynch HT
Cancer; 2001 Jun; 91(12):2417-22. PubMed ID: 11413533
[TBL] [Abstract][Full Text] [Related]
9. [Immune response and colorectal cancer].
Tougeron D; Fauquembergue E; Latouche JB
Bull Cancer; 2013 Mar; 100(3):283-94. PubMed ID: 23501583
[TBL] [Abstract][Full Text] [Related]
10. Tumour-infiltrating lymphocytes in colorectal cancer with microsatellite instability are activated and cytotoxic.
Phillips SM; Banerjea A; Feakins R; Li SR; Bustin SA; Dorudi S
Br J Surg; 2004 Apr; 91(4):469-75. PubMed ID: 15048750
[TBL] [Abstract][Full Text] [Related]
11. High density of FOXP3-positive T cells infiltrating colorectal cancers with microsatellite instability.
Michel S; Benner A; Tariverdian M; Wentzensen N; Hoefler P; Pommerencke T; Grabe N; von Knebel Doeberitz M; Kloor M
Br J Cancer; 2008 Dec; 99(11):1867-73. PubMed ID: 18985040
[TBL] [Abstract][Full Text] [Related]
12. Tumor-Infiltrating Lymphocytes, Crohn's-Like Lymphoid Reaction, and Survival From Colorectal Cancer.
Rozek LS; Schmit SL; Greenson JK; Tomsho LP; Rennert HS; Rennert G; Gruber SB
J Natl Cancer Inst; 2016 Aug; 108(8):. PubMed ID: 27172903
[TBL] [Abstract][Full Text] [Related]
13. Comment re: Intratumoral immune reaction in human colorectal cancer.
Speetjens FM; Kuppen PJ
Cancer Res; 2010 Feb; 70(4):1741; author reply 1741. PubMed ID: 20145146
[No Abstract] [Full Text] [Related]
14. T cell subsets and colorectal cancer: discerning the good from the bad.
Scurr M; Gallimore A; Godkin A
Cell Immunol; 2012 Sep; 279(1):21-4. PubMed ID: 23041206
[TBL] [Abstract][Full Text] [Related]
15. The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer.
Roxburgh CS; McMillan DC
Cancer Treat Rev; 2012 Aug; 38(5):451-66. PubMed ID: 21945823
[TBL] [Abstract][Full Text] [Related]
16. Tumor infiltrating T lymphocytes in colorectal cancer: Tumor-selective activation and cytotoxic activity in situ.
Koch M; Beckhove P; Op den Winkel J; Autenrieth D; Wagner P; Nummer D; Specht S; Antolovic D; Galindo L; Schmitz-Winnenthal FH; Schirrmacher V; Büchler MW; Weitz J
Ann Surg; 2006 Dec; 244(6):986-92; discussion 992-3. PubMed ID: 17122624
[TBL] [Abstract][Full Text] [Related]
17. [Correlation between microsatellite instability and morphology in colorectal cancer].
Szentirmay Z; Gallai M; Serester O; Szoke J; Tóth E
Magy Onkol; 2010 Jun; 54(2):169-78. PubMed ID: 20576594
[TBL] [Abstract][Full Text] [Related]
18. The Ratio of Exhausted to Resident Infiltrating Lymphocytes Is Prognostic for Colorectal Cancer Patient Outcome.
Foroutan M; Molania R; Pfefferle A; Behrenbruch C; Scheer S; Kallies A; Speed TP; Cursons J; Huntington ND
Cancer Immunol Res; 2021 Oct; 9(10):1125-1140. PubMed ID: 34413087
[TBL] [Abstract][Full Text] [Related]
19. High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer.
Hojo S; Koizumi K; Tsuneyama K; Arita Y; Cui Z; Shinohara K; Minami T; Hashimoto I; Nakayama T; Sakurai H; Takano Y; Yoshie O; Tsukada K; Saiki I
Cancer Res; 2007 May; 67(10):4725-31. PubMed ID: 17510400
[TBL] [Abstract][Full Text] [Related]
20. Tumor-associated antigen recognized by the 22-1-1 monoclonal antibody encourages colorectal cancer progression under the scanty CD8+ T cells.
Oshikiri T; Miyamoto M; Morita T; Fujita M; Miyasaka Y; Senmaru N; Yamada H; Takahashi T; Horita S; Kondo S
Clin Cancer Res; 2006 Jan; 12(2):411-6. PubMed ID: 16428480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
